• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防性使用牛磺罗定枸橼酸盐封管对 2 岁以下手术患儿导管相关感染数量的影响。

Effects of prophylactic use of taurolidine-citrate lock on the number of catheter-related infections in children under 2 years of age undergoing surgery.

机构信息

Department of Paediatric Surgery and Organ Transplantation, Children's Memorial Health Institute, Warsaw, Poland.

Department of Paediatric Surgery and Organ Transplantation, Children's Memorial Health Institute, Warsaw, Poland.

出版信息

J Hosp Infect. 2019 Oct;103(2):223-226. doi: 10.1016/j.jhin.2019.04.022. Epub 2019 May 2.

DOI:10.1016/j.jhin.2019.04.022
PMID:31054935
Abstract

Central venous access poses a risk for the development of catheter-related infections (CRIs). The aim of this study was to evaluate prophylactic use of taurolidine-citrate (T-C) solution on the number of CRIs. Ninety-seven catheters, used in 86 children, were divided at random into two groups: Group T(-) (N=49) underwent standard aseptic procedures, and Group T(+) (N=48) received additional filling of the lines with T-C solution during intervals in cycles of parenteral nutrition or drug supply. Sixteen CRIs occurred in Group T(-) and one CRI occurred in Group T(+); this difference was significant (P<0.05). Use of T-C appears to be a safe and effective method for the prevention of CRIs.

摘要

中心静脉置管有发生导管相关性感染(CRI)的风险。本研究旨在评估牛磺罗定-柠檬酸盐(T-C)溶液在预防 CRI 方面的作用。97 根导管在 86 名儿童中随机分为两组:T(-)组(N=49)采用标准无菌操作,T(+)组(N=48)在接受肠外营养或药物供应周期的间歇期间,额外向导管内注入 T-C 溶液。T(-)组发生 16 例 CRI,T(+)组发生 1 例 CRI,差异有统计学意义(P<0.05)。T-C 的使用似乎是预防 CRI 的一种安全有效的方法。

相似文献

1
Effects of prophylactic use of taurolidine-citrate lock on the number of catheter-related infections in children under 2 years of age undergoing surgery.预防性使用牛磺罗定枸橼酸盐封管对 2 岁以下手术患儿导管相关感染数量的影响。
J Hosp Infect. 2019 Oct;103(2):223-226. doi: 10.1016/j.jhin.2019.04.022. Epub 2019 May 2.
2
Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.柠檬酸牛磺菌素与肝素在儿童血液恶性肿瘤患者中作为导管封管液的随机对照试验。
J Hosp Infect. 2012 Apr;80(4):304-9. doi: 10.1016/j.jhin.2012.01.003. Epub 2012 Feb 18.
3
Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).使用牛磺罗定 - 柠檬酸盐封管溶液预防成年中性粒细胞减少血液学患者中心静脉导管感染:一项随机、双盲、安慰剂对照试验(TAURCAT)
Trials. 2018 May 2;19(1):264. doi: 10.1186/s13063-018-2647-y.
4
Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.基于牛磺罗定的导管封管方案可显著降低隧道式血液透析导管的总费用、感染率和功能障碍发生率。
Kidney Int. 2018 Mar;93(3):753-760. doi: 10.1016/j.kint.2017.06.026. Epub 2017 Sep 8.
5
Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock.经替考拉宁管路封管治疗后,开始 HPN 的儿童中心静脉导管相关血流感染显著减少。
J Pediatr Gastroenterol Nutr. 2012 Oct;55(4):403-7. doi: 10.1097/MPG.0b013e31825bb0ae.
6
Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.成人家庭肠外营养中使用牛磺罗定封管:一项开放标签随机对照临床试验的结果
JPEN J Parenter Enteral Nutr. 2015 Mar;39(3):331-5. doi: 10.1177/0148607114525804. Epub 2014 Mar 6.
7
A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients.一项随机、双盲、安慰剂对照试验(TAURCAT 研究),评估柠檬酸锁溶液预防中性粒细胞减少性血液病患者中心静脉导管腔内感染的效果。
Antimicrob Agents Chemother. 2020 Jan 27;64(2). doi: 10.1128/AAC.01521-19.
8
Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.使用含枸橼酸-牛磺罗定的封管溶液预防透析导管相关败血症。
Nephrol Dial Transplant. 2004 Jun;19(6):1546-51. doi: 10.1093/ndt/gfh014. Epub 2004 Feb 19.
9
Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC).牛磺罗定/柠檬酸盐封管疗法用于癌症患者导管相关感染的一级预防:一项前瞻性、随机、IV期试验(ATAPAC)的结果
Oncology. 2017;93(2):99-105. doi: 10.1159/000470911. Epub 2017 May 3.
10
Strategies to Reduce Catheter-Related Bloodstream Infections in Pediatric Patients Receiving Home Parenteral Nutrition: The Efficacy of Taurolidine-Citrate Prophylactic-Locking.降低接受家庭肠外营养的儿科患者导管相关血流感染的策略:牛磺罗定-柠檬酸盐预防封管的疗效。
JPEN J Parenter Enteral Nutr. 2018 Aug;42(6):1017-1025. doi: 10.1002/jpen.1043. Epub 2018 Jan 31.

引用本文的文献

1
Antimicrobial Lock Therapy in Clinical Practice: A Scoping Review.临床实践中的抗菌封管疗法:一项范围综述
Microorganisms. 2025 Feb 13;13(2):406. doi: 10.3390/microorganisms13020406.
2
Meta-analysis of the efficacy of taurolidine in reducing catheter-related bloodstream infections for patients receiving parenteral nutrition.牛磺罗定对接受肠外营养患者减少导管相关血流感染疗效的Meta分析。
JPEN J Parenter Enteral Nutr. 2022 Sep;46(7):1535-1552. doi: 10.1002/jpen.2363. Epub 2022 Mar 25.
3
Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: A meta-analysis.
替考拉宁封管液在小儿患者导管相关血流感染中的应用:一项荟萃分析。
PLoS One. 2020 Apr 7;15(4):e0231110. doi: 10.1371/journal.pone.0231110. eCollection 2020.